46 filings
8-K
APGE
Apogee Therapeutics Inc.
7 Jun 24
Submission of Matters to a Vote of Security Holders
4:02pm
DEFA14A
APGE
Apogee Therapeutics Inc.
28 May 24
Additional proxy soliciting materials
7:36am
8-K
APGE
Apogee Therapeutics Inc.
28 May 24
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
7:35am
8-K
APGE
Apogee Therapeutics Inc.
15 May 24
Regulation FD Disclosure
4:39pm
S-8
APGE
Apogee Therapeutics Inc.
13 May 24
Registration of securities for employees
7:26am
8-K
v6lts vgrict3tjq
13 May 24
Apogee Therapeutics Highlights Pipeline Progress and Reports First Quarter 2024 Financial Results
7:05am
ARS
e193cb
24 Apr 24
Annual report to shareholders
4:18pm
DEFA14A
wvsr1
24 Apr 24
Additional proxy soliciting materials
4:16pm
DEF 14A
9u864 q1kwayhio
24 Apr 24
Definitive proxy
4:15pm
8-K
ynvq5k
25 Mar 24
Regulation FD Disclosure
7:30am
424B4
7chshs0
11 Mar 24
Prospectus supplement with pricing info
6:01am
EFFECT
euezrj
8 Mar 24
Notice of effectiveness
12:15am
S-1MEF
fuo91
7 Mar 24
Registration of additional securities for an S-1
6:27pm
8-K
znf5elvv8 hqj
5 Mar 24
Regulation FD Disclosure
8:15am
10-K
59chty9pm4j hqeitkh5
5 Mar 24
Annual report
6:15am
8-K
4wjs6xz6dp5
5 Mar 24
Apogee Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
6:11am
DRS
mnzqb9x2 xhwc9p70h
9 Feb 24
Draft registration statement
12:00am